Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / *W EXP 10/01/202
-
Total 13F shares
-
6,320,063
-
Share change
-
+5,516,742
-
Total reported value
-
$1,364,295
-
Price per share
-
$0.20
-
Number of holders
-
31
-
Value change
-
+$1,199,662
-
Number of buys
-
30
Institutional Holders of Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 (BDMDW) as of Q4 2024
As of 31 Dec 2024,
Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 (BDMDW) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,320,063 shares.
The largest 10 holders included
GRITSTONE ASSET MANAGEMENT LLC, Sculptor Capital LP, Calamos Advisors LLC, Kepos Capital LP, CLEAR STREET LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Linden Advisors LP, Davidson Kempner Capital Management LP, Shaolin Capital Management LLC, and Sandia Investment Management LP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.